CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.

作者: Sarah F. Schillie , Trudy V Murphy , Mark Sawyer , Kathleen Ly , Elizabeth Hughes

DOI:

关键词:

摘要: This report contains CDC guidance that augments the 2011 recommendations of Advisory Committee on Immunization Practices (ACIP) for evaluating hepatitis B protection among health-care personnel (HCP) and administering post-exposure prophylaxis. Explicit is provided persons working, training, or volunteering in settings who have documented (HepB) vaccination years before hire matriculation (e.g., when HepB was received as part routine infant [recommended since 1991] catch-up adolescent 1995] vaccination). In United States, 2,890 cases acute were reported to 2011, an estimated 18,800 new occurred after accounting underreporting asymptomatic infection. Although rate virus (HBV) infections declined approximately 89% during 1990-2011, from 8.5 0.9 per 100,000 population risk occupationally acquired HBV HCP persists, largely exposures patients with chronic ACIP recommends unvaccinated incompletely vaccinated reasonably anticipated blood body fluid exposure. also receive postvaccination serologic testing (antibody surface antigen [anti-HBs]) 1-2 months final dose vaccine administered (CDC. personnel: [ACIP]. MMWR 2011;60 [No. RR-7]). Increasing numbers either infants (recommended 1991) 1995) adolescence. results protective anti-HBs responses 95% healthy-term infants. Certain institutions test by measuring upon matriculation, even occurs greater than 2 vaccination. can assist clinicians, occupational health student providers, infection-control specialists, hospital training program administrators, others selection approach assessing HCP. emphasizes importance all HCP, provides explicit previously (particularly those infancy adolescence), clarifies postexposure management exposed fluids.

参考文章(69)
Adelisa L Panlilio, Walid Heneine, Lisa A Grohskopf, Denise M Cardo, Clara Sue Ross, Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weekly Report. ,vol. 54, pp. 1- 17 ,(2005)
Francisco Averhoff, Frank Mahoney, Patrick Coleman, Gary Schatz, Eugene Hurwitz, Harold Margolis, Immunogenicity of Hepatitis B Vaccines Implications for Persons at Occupational Risk of Hepatitis B Virus Infection American Journal of Preventive Medicine. ,vol. 15, pp. 1- 8 ,(1998) , 10.1016/S0749-3797(98)00003-8
Tamara Pilishvili, Craig M. Hales, Peng-Jun Lu, Carolyn B. Bridges, Alissa O’Halloran, Lauri E. Markowitz, Walter W. Williams, Noninfluenza vaccination coverage among adults - United States, 2012. Morbidity and Mortality Weekly Report. ,vol. 63, pp. 95- 102 ,(2014)
Erin Rusch, Andrew Ford, Kathleen Stratton, Ellen Wright Clayton, Adverse Effects of Vaccines: Evidence and Causality ,(2013)
Y. Poovorawan, V. Chongsrisawat, A. Theamboonlers, G. Leroux-Roels, S. Kuriyakose, M. Leyssen, J.-M. Jacquet, Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region Journal of Viral Hepatitis. ,vol. 18, pp. 369- 375 ,(2011) , 10.1111/J.1365-2893.2010.01312.X
Thomas Lee, Patricia E. Taylor, Pearl T. Toy, Hoo-Yi Yip, Cladd E. Stevens, Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics. ,vol. 90, pp. 170- 173 ,(1992)
Maurice Levy, Gideon Koren, Hepatitis B vaccine in pregnancy: maternal and fetal safety. American Journal of Perinatology. ,vol. 8, pp. 227- 232 ,(1991) , 10.1055/S-2007-999384
Daniel W. Martin, N. Elaine Lowery, Bill Brand, Rebecca Gold, Gail Horlick, Immunization Information Systems Journal of Public Health Management and Practice. ,vol. 21, pp. 296- 303 ,(2015) , 10.1097/PHH.0000000000000040
JOHANNA GOLDFARB, JILL BALEY, SHARON VANDERBRUG MEDENDORP, DEXTER SETO, HAYDEE GARCIA, PEARL TOY, BARBARA WATSON, MANFORD W. GOOCH, DAVID KRAUSE, Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B® hepatitis B vaccine in neonates Pediatric Infectious Disease Journal. ,vol. 13, pp. 18- 22 ,(1994) , 10.1097/00006454-199401000-00005
A. M. Prince, W. Szmuness, M. K. Mann, G. N. Vyas, G. F. Grady, F. L. Shapiro, W. N. Suki, E. A. Freidman, M. M. Avram, K. H. Stenzel, Hepatitis B Immune Globulin: Final Report of a Controlled, Multicenter Trial of Efficacy in Prevention of Dialysis-Associated Hepatitis The Journal of Infectious Diseases. ,vol. 137, pp. 131- 144 ,(1978) , 10.1093/INFDIS/137.2.131